AIM ImmunoTech
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. AIM ImmunoTech's past years’ income statements indicate that its last revenue has increased compared to the previous period by 43% to $202,000. Profit margin reached -14338%. Total operating expenses were $32,076,000.

Profit Margin

AIM ImmunoTech Inc. (AMEX:AIM): Profit margin
2014 197K -17.45M -8857.87%
2015 133K -15.23M -11451.13%
2016 92K -7.50M -8154.35%
2017 437K -8.25M -1889.93%
2018 367K -9.81M -2673.84%
2019 140K -10.82M -7732.86%
2020 163K -16.25M -9974.23%
2021 135K -21.51M -15935.56%
2022 141K -21.08M -14954.61%
2023 202K -28.96M -14337.62%

AIM Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
202K141K135K163K140K367K437K92K133K197K
Cost of revenue
42K19.92M850K806K893K884K1.18M1.10M1.59M1.25M
Gross profit
160K-19.78M-715K-643K-753K-517K-746K-1.01M-1.46M-1.05M
Operating exp.
Research and development
10.93M6.99M7.67M5.72M4.65M4.77M4.09M5.10M8.03M8.98M
Selling and marketing
0000000000
Total operating expenses
32.07M20.06M16.34M14.37M11.69M10.97M10.67M12.78M15.18M18.04M
Operating income
-31.91M-19.92M-18.83M-15.15M-12.44M-11.49M-11.41M-13.80M-16.65M-19.09M
Other income (expenses), net
2.95M478K-289K752K2.91M2.13M3.15M6.17M1.41M1.64M
Income before tax
-28.96M-19.44M-19.12M-14.4M-9.53M-9.81M-8.25M-7.50M-15.23M-17.45M
Income tax expense
01.64M2.38M1.85M1.29M2.18M3.34M03K11K
Net income
-28.96M-21.08M-21.51M-16.25M-10.82M-9.81M-8.25M-7.50M-15.23M-17.45M
Earnings per share
Basic EPS
-0.6-0.44-0.45-0.51-2.97-9.77-12.67-15.13-34.05-48.93
Diluted EPS
-0.6-0.44-0.45-0.51-2.97-9.77-12.67-15.13-34.05-48.93
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source